title: Modified MicroSecure Vitrification: A Safe, Simple and Highly Effective Cryopreservation Procedure for Human Blastocysts.
abstract: Clinical embryo vitrification evolved with the development of unique vitrification devices in the 21stcentury and with the misconception that ultra-rapid cooling in an "open" system (i.e., direct LN2 contact) was a necessity to optimize vitrification success. The dogma surrounding the importance of cooling rates led to unsafe practices subject to technical variation and to the creation of vitrification devices that disregarded important quality-control factors (e.g., ease of use, repeatability, reliability, labeling security, and storage safety). Understanding the quality-control flaws of other devices allowed for the development of a safe, secure, repeatable, and reliable µS-VTF method aimed to minimize intra- and inter-technician variation. Equally important, it combined the availability of two existing FDA-compliant devices: 1) a 0.3-mL ionomeric resin embryo straw with internalized, dual-colored, tamper-proof labeling with repeatable weld seal potential; and 2) shortened, commonly-used, 300-µm ID sterile flexipettes to directly load the embryo(s) in order to create a highly-effective global vitrification device. Like other aseptic, closed vitrification systems (e.g., High Security Vitrification (HSV), Rapid-i, and VitriSafe) effectively used in reproductive medicine, microSecure Vitrification (µS-VTF) has proven that it can achieve high post-warming survival and pregnancy outcomes with its attention to simplicity, and reduced technical variation. Although the 0.3-mL embryo straw containing an internal hydrophobic plug was commercially replaced with a standard semen straw possessing cotton-polyvinyl pyrrolidone (PVP) plugs, it maintained its ionomeric resin composition to ensure weld sealing. However, the cotton plugs can wick out the fluid-embryo contents of the flexipettes upon contact. A modified µS-VTF method was adapted to include an additional internal weld seal before the plug on the device loading side. The added technical step to the µS-VTF procedure has not affected its successful application, as high survival rates (> 95%) and pregnancy rates continue today.
authors.affiliation: Ovation Fertility; mcschiewe@verizon.net.
authors.forename: Mitchel C
authors.initials: MC
authors.lastname: Schiewe
authors.affiliation: Ovation Fertility.
authors.forename: Shane
authors.initials: S
authors.lastname: Zozula
authors.affiliation: Ovation Fertility.
authors.forename: Nancy
authors.initials: N
authors.lastname: Nugent
authors.affiliation: Ovation Fertility.
authors.forename: Kelley
authors.initials: K
authors.lastname: Waggoner
authors.affiliation: Ovation Fertility.
authors.forename: Jessica
authors.initials: J
authors.lastname: Borba
authors.affiliation: Ovation Fertility.
authors.forename: Lisa
authors.initials: L
authors.lastname: Gamboa
authors.affiliation: Ovation Fertility.
authors.forename: John B
authors.initials: JB
authors.lastname: Whitney
mesh_terms: D001755:Blastocyst / Q000166:cytology*; D015925:Cryopreservation / Q000379:methods*; D004624:Embryo Transfer / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D011247:Pregnancy; D011256:Pregnancy Outcome; D018873:Pregnancy Rate; D015203:Reproducibility of Results; D012661:Semen / Q000166:cytology*; D058989:Vitrification